Q&A with Melanoma March Fundraisers

Q&A with Melanoma March Fundraisers

10 March 2015

Adrienne and Georgia lost their mother Patricia in 2009. They are taking part in this year's Melanoma March for the second time and hope that with their fundraising they can help another family go through what they had to. Read about how they are rallying their team together and hope to raise as much as possible. 

Why are you taking part in this years Melanoma March?

We are taking part in this year's Melanoma March as we sadly lost our mother in 2009 to this aggressive disease. Mum first found her mole on the inside of year leg 14 years prior to her death. Adrienne was in year 1 and Georgia was in year 11. At the time, both of us didn’t quite comprehend the seriousness of her illness, nor did we expect that it would return some years later. Mum went into remission and in 2008 we discovered that the cancer had returned and was growing in her abdomen. After major surgery to remove the cancer we received the news that the cancer had spread to many of Mum’s organs. Within a few months it eventually reached her brain and Mum lost her battle. Our Mum wasn’t lucky enough to have the option of the trials and programs that are offered to melanoma patients now. Upon her first diagnosis in 1994 there were very limited options and when the cancer returned, it was too late for her. We are marching to raise awareness of melanoma in the hope that people avoid the harsh sun, understand the dangers of UV exposure and maintain regular skin check ups – whether they have had melanoma in the past, are predisposed to it or just need to keep an eye out for changes. In addition to raised awareness it is so important to continue to raise funds in order to fund important trials. We can only dream about what could have been a better outcome for our mother. Yet we hope that other individuals can get access to such valuable treatment that our mum couldn’t. If our fundraising can help the lives of another family to not go through what we did, we will do all we can.

How are you fundraising for your team? 

We have contacted all our friends and families and asked them to march with us or make a donation to our team. Friends are holding morning teas at work to rally marchers and raise funds. Adrienne is a school teacher and will be sharing her story and having a guest speaker at her school this week.

How many people are in your team?

At present we have around 20 marchers who will be walking with us. We hope this number will continue to grow this week!

What are some of your tips to get your friends and family to donate?

The power of social media is great. We have been posting daily reminders to donate and register and set up a facebook event which we regularly update. Sending out SMS reminders has also been effective. We find that thanking people publicly on Facebook everytime we receive a donation helps to remind people as well as provide positive encouragement for others! We have asked members of our team to repost the link to register and donate. The last year our team marched in Manly we raised over $2000. We are close to $1000 at the moment and are pushing for more donations to come through this week. It would be amazing to match or beat our last effort. We find that most people donate in the week leading up to the event. 

Donate now. Every bit counts towards a cure.
 

Patients to benefit from updated skin tumour publications
26 Oct 2018

Patients to benefit from updated skin tumour publications

Two publications co-edited by MIA Co-Medical Director Professor Richard Scolyer are now available to healthcare professionals. They aim to provide assistance in the care and management of patients with skin cancer, including melanoma.

SunSafe Student Ambassador Program
25 Oct 2018

SunSafe Student Ambassador Program

Melanoma Institute Australia has introduced a new educational program to teach teenagers about the dangers of melanoma and the importance of sun safety. 

International collaboration the key to increasing survival
24 Oct 2018

International collaboration the key to increasing survival

"International collaboration remains the key to ensuring this pioneering research continues so we can increase survival rates for advanced melanoma patients and move us closer to achieving our goal of zero deaths from melanoma," says Professor Georgina Long, of the clinical trial results presented at ESMO 2018.

High-risk Stage III melanoma patients to benefit from Australia/Netherlands collaboration
23 Oct 2018

High-risk Stage III melanoma patients to benefit from Australia/Netherlands collaboration

Research that could change clinical practice for high-risk Stage III melanoma patients has been presented at the European Society for Medical Oncology (ESMO) Congress in Munich.

Monthly dose of immunotherapy allows flexibility for patients undergoing treatment
11 Oct 2018

Monthly dose of immunotherapy allows flexibility for patients undergoing treatment

A larger, monthly dose of immunotherapy can give melanoma patients more freedom without sacrificing effectiveness.

Australia's best minds in melanoma research converge on Melbourne
08 Oct 2018

Australia's best minds in melanoma research converge on Melbourne

The Australasian Melanoma Conference, hosted by the Australasian Melanoma Conference Committee, was held in Melbourne on the weekend, with many of MIA's clinicians in attendance.

Nobel Prize for novel cancer therapies
04 Oct 2018

Nobel Prize for novel cancer therapies

The two men who discovered checkpoint inhibitors, the brakes of the immune system, were awarded the Nobel Prize in Physiology or Medicine on Monday, October 1.

World Health Organisation launches 4th edition of Classification of Skin Tumours
31 Aug 2018

World Health Organisation launches 4th edition of Classification of Skin Tumours

The World Health Organisation (WHO) is releasing the 4th edition of Classification of Skin Tumours.

Professor John Thompson awarded prestigious 2018 RPA Foundation Research Medal
31 Aug 2018

Professor John Thompson awarded prestigious 2018 RPA Foundation Research Medal

Former Executive Director of Melanoma Institute Australia Professor John Thompson awarded the prestigious 2018 RPA Foundation Research Medal.

Support PBS listing for pembrolizumab
23 Aug 2018

Support PBS listing for pembrolizumab

Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for pembrolizumab.

World Congress on Cancers of the Skin 2018
17 Aug 2018

World Congress on Cancers of the Skin 2018

The World Congress on Cancers of the Skin 2018 has featured many minds from MIA sharing their expertise and wealth of knowledge with over 1000 attendees from around the world.

Melanoma Institute Australia welcomes new CEO Matthew Browne
09 Aug 2018

Melanoma Institute Australia welcomes new CEO Matthew Browne

Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).

Melanoma in Practice: Nurse Conference
26 Jul 2018

Melanoma in Practice: Nurse Conference

It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’. 

Reducing the risk of melanoma in young adults
19 Jul 2018

Reducing the risk of melanoma in young adults

A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.

Melanoma Institute Australia launches free e-learning education portal
20 Jun 2018

Melanoma Institute Australia launches free e-learning education portal

Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.

David Day and a lifetime of missed moments
08 Jun 2018

David Day and a lifetime of missed moments

When David lost his life last year, he was 33, with three daughters under six.

Australian melanoma experts share latest breakthroughs with world's best oncologists
06 Jun 2018

Australian melanoma experts share latest breakthroughs with world's best oncologists

ASCO 2018 brings together the world's best in oncology from around the world. 

ASCO 2018 – the important role of clinical trials
06 Jun 2018

ASCO 2018 – the important role of clinical trials

Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.

MIA Scoops Awards at the International Academy of Pathology
04 Jun 2018

MIA Scoops Awards at the International Academy of Pathology

Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology. 

Updated Clinical Guidelines for Melanoma
25 May 2018

Updated Clinical Guidelines for Melanoma

Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.